Results 171 to 180 of about 203,814 (292)
Occupational Allergy to Rat and Mouse in Research Laboratories. [PDF]
Caron J +4 more
europepmc +1 more source
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
Marie‐Thérèse Armentero +5 more
openalex +2 more sources
The interaction between trophoblasts and decidual polymorphonuclear myeloid‐derived suppressor cells (dPMN‐MDSCs) via the XCL1–XCR1 axis is crucial for fetal development during the third trimester. Disruption of this axis impairs FOXO1 activity and causes metabolic imbalance in dPMN‐MDSCs, contributing to adverse outcomes associated with advanced ...
Meiqi Chen +12 more
wiley +1 more source
Cryptosporidium spp. in wild rodents in the Poyang Lake region, China. [PDF]
Zuo Q +11 more
europepmc +1 more source
First Molecular Detection and characterization of Borrelia burgdorferi sensu lato (Lyme disease spirochete) in Egyptian rodents [PDF]
Mohamed W. Ghafar +3 more
openalex +1 more source
This study reveals that XBP1s drives production of circTspan3, a circular RNA that strengthens cartilage by boosting anabolic activity and limiting cell death. Phosphorylated ANXA2 directs circTspan3 into exosomes, enabling paracrine repair. Exosomal circTspan3 expands growth‐plate cartilage and promotes in vivo regeneration, highlighting its promise ...
Yiming Pan +16 more
wiley +1 more source
P2‐255: The retina as a window to monitor Alzheimer's disease in human and rodent models: In vivo imaging of retinal Aβ plaques for immunotherapy assessment [PDF]
Yosef Koronyo +7 more
openalex +1 more source
A Modular Vaccine Platform Against SARS‐CoV‐2 Based on Self‐Assembled Protein Nanoparticles
A modular BP26 nanoparticle vaccine platform incorporating the SpyTag/SpyCatcher system enables high‐density, repetitive antigen display with post‐expression flexibility. Conjugation of the SARS‐CoV‐2 RBD to BP26 nanoparticles elicits strong humoral immunity and confers protection against viral challenge in vivo.
Seojung Lee +6 more
wiley +1 more source

